Autres langues Gedeon Richter

Actions

RICHTER

HU0000123096

Produits pharmaceutiques

PEA

Marché Fermé - Budapest S.E. 17:19:59 18/09/2026			Varia. 5j.	Varia. 1 janv.
12 830,00 ^HUF	+0,39 %		+2,39 %	+30,06 %

18/09	L'Agence européenne des médicaments émet un avis favorable sur le traitement de Gedeon Richter contre l'arthrite	MT
11/08	Transcript : Gedeon Richter PLC, Q2 2026 Earnings Call, Aug 07, 2026

Autres langues

18/09	EU Medicines Agency Panel Issues Positive Opinion on Gedeon Richter's Arthritis Drug
07/08	Gedeon Richter PLC Reports Earnings Results for the Half Year Ended June 30, 2026
07/08	Gedeon Richter : Richter publishes Q2/H1 2026 results
06/08	Gedeon Richter : Richter and Adalvo Expand Global Co-Development Partnership in Tirzepatide Across Diabetes and Obesity Care
06/08	Gedeon Richter plc and Adalvo Expand Global Co-Development Partnership in Tirzepatide Across Diabetes and Obesity Care
29/06	Gedeon Richter plc announces Resignation of Péter Cserháti as Member of the Board of Directors, with Effect from 1 July 2026
16/06	AI in Hungary could unlock productivity gains of EUR15 billion, McKinsey says
10/06	Gedeon Richter : Richter and Hetero Announce Global Cooperation for the Development and Commercialization of Semaglutide Injection (Generic of Ozempic®)
10/06	Gedeon Richter Plc. and Hetero Labs Ltd. Announce Global Collaboration Agreement for Joint Development, Registration, and Commercialization of Semaglutide Injection
29/05	Gedeon Richter PLC Approves Dividend for the Financial Year 2025
27/05	Hungary's Richter and Acrux agree to license transdermal estradiol spray for Australia
27/05	Gedeon Richter : Richter and Acrux agree to license Lenzetto® for Australia
14/05	Gedeon Richter : Transactions with Treasury Shares
12/05	Gedeon Richter PLC Reports Earnings Results for the First Quarter Ended March 31, 2026
12/05	Gedeon Richter : Extraordinary Information
12/05	Hungary's Richter says 2026 guidance fully reiterated high-single-digit growth in revenues and clean EBIT (at constant exchange rates)
12/05	Gedeon Richter : Interim management statement
12/05	Gedeon Richter : RichterIRpresentation May 2026
12/05	Gedeon Richter : PresentationQ12026
12/05	Gedeon Richter : Richter publishes Q1 2026 results
12/05	Gedeon Richter : Earnings presentation Q1 2026 (PresentationQ12026)
12/05	Gedeon Richter : Investor presentation Q1 2026 (RichterIRpresentation May 2026)
12/05	Gedeon Richter Seeks Acquisitions
29/04	Gedeon Richter : Corporate Governance Report from 2025
29/04	Gedeon Richter : AGM Resolutions